Phone: +44 7706 773593‬
Email: xygpeptides@163.com
Tirzepatide（Mounjaro）5mg 10mg 15mg Injection

Tirzepatide（Mounjaro）5mg 10mg 15mg Injection

Tirzepatide（Mounjaro）5mg 10mg 15mg Injection

Tirzepatide（Mounjaro）5mg 10mg 15mg Injection

Short Description:

Name: Tirzepatide

Specs: 5mg/vial*10vials/box 10mg/vial*10vial /box 15mg/vial*10vial/box

Lab: XYG Bio

MOQ: 1 box

Whatsapp:+86 18261582514


Ossza meg
letöltés pdf-be

Részletek

Címkék

Tirzepatide

Tirzepatide is an investigational once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist that integrates the actions of both incretins into a single molecule.

Tirzepatide Mimics Natural Hormones that Foster Feeling Full
Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety.

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) recepto agonist, which is FDA-approved for treating type 2 diabetes mellitus. It is important to note that tirzepatide is not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis. Tirzepatide is a GIP receptor and GLP-1 receptor agonist, leading to significantly improved glycemic control in type 2 diabetics and significant weight reduction.

The FDA approved Tirzepatide in May 2022. Tirzepatide can also be used off-label for treating obesity. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications like semaglutide. It is a once-a-week subcutaneous injectable medication with incremental dose increases.

Current clinical data has demonstrated that tirzepatide is superior to placebo in improving hemoglobin A1C levels. The SURPASS-5 clinical trial showed a -2.11% reduction in hemoglobin A1C levels at 5mg per week dosing, compared to -0.86% with placebo. At the highest dose of 15 mg per week, tirzepatide led to a -2.34% reduction in hemoglobin A1C. This was demonstrated over 40 weeks. A weight reduction of 5.4 kg was seen with 5mg of tirzepatide dosing, and a 10.5 kg reduction was seen with 15 mg dosing. This dose-dependent correlation with weight loss is similar to semaglutide, a common GLP-1 medication utilized for weight loss management.

Comparatively, tirzepatide has been shown to work similarly to GLP-1 medications but with greater efficacy. Given its weight loss properties and lack of liver toxicity, it is likely to play an indirect role in the treatment of nonalcoholic fatty liver disease (NAFLD) as well.

NOTE

We ship all over the world.
You are advised to consult your medical consultations before use of the product.

Ha felkeltette érdeklődését termékeink, itt hagyhatja adatait, és hamarosan felvesszük Önnel a kapcsolatot.


Írja ide üzenetét és küldje el nekünk
Asset 3

Kell segítség?
Írjon nekünk üzenetet az alábbi űrlap segítségével.

Ha felkeltette érdeklődését termékeink, itt hagyhatja adatait, és hamarosan felvesszük Önnel a kapcsolatot.


hu_HUHungarian
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu hu_HUHungarian